Nucleos(t)ide withdrawal vs Nucleos(t)ide withdrawal with adjuvant pegylated-interferon in HBeAg-negative hepatitis B virus infection (NUC-B Trial)

Hepatology · Published 2026-08-04 · DOI 10.1097/hep.0000000000001821

Free full text

Authors (23)

Mark Thursz, Maud Lemoine, Ashley Brown, Ivana Carey, Jack Message, Patrick Kennedy, Daniel Forton, Martin Wiselka, Mark Aldersley, Martin Prince, Stuart McPherson, Sandra Phillips, Shilpa Chokshi, Alice Burton, Mala Maini, Johannes Christiaan Botha, Eleni Nastouli, Samantha Tsao, Emanuela Falaschetti, Hanna Box, Mariam Habib, Kaushik Agarwal, on behalf of the NUC-B Study Group

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year
2026

Citation

Thursz, M., Lemoine, M., Brown, A., et al. (2026). Nucleos(t)ide withdrawal vs Nucleos(t)ide withdrawal with adjuvant pegylated-interferon in HBeAg-negative hepatitis B virus infection (NUC-B Trial). Hepatology. https://doi.org/10.1097/hep.0000000000001821

Related articles